LPA2 receptor-containing complexes in regulating secretory diarrhea
Project Number7R01DK093045-04
Contact PI/Project LeaderNAREN, ANJAPARAVANDA P
Awardee OrganizationCINCINNATI CHILDRENS HOSP MED CTR
Description
Abstract Text
DESCRIPTION (provided by applicant): The unifying hypothesis of this proposal is that macromolecular complex of type 2 lysophosphatidic acid receptor (LPA2 receptor) and Na+/H+ exchange regulatory factor-2 (NHERF2) plays important roles in the pathogenic process of secretory diarrhea. We aim to study the formation and regulation of the macromolecular complex at the molecular level under physiological and pathophysiological conditions that play a critical role in cholera induced diarrhea. Moreover, the research will study the mechanism through which LPA2 receptor- mediated signaling events regulate CFTR-dependent electrolyte secretion in cells and fluid secretion in an animal model of diarrhea. Three aims will be studied: Aim 1: To test the hypothesis that LPA2 receptor is primarily expressed on the luminal surface of the gut and is down regulated in certain forms of diarrheal diseases, and to test the hypothesis that activation of LPA2 receptor inhibits compartmentalized cAMP generation at the plasma membrane. Aim 2: To test the hypothesis that LPA can regulate the formation of the LPA2-containing macromolecular complex by further clustering it to microdomain on the plasma membrane and that the process is mediated by NHERF2-dependent protein-protein interactions Aim 3: To test the hypothesis that disruption of the macromolecular complex by silencing NHERF2 alters compartmentalized cAMP levels at the plasma membrane and that in vivo NHERF2 knockout mice generate altered cAMP in response to CTX. The proposal is of great importance and significance for understanding the pathogenic process of the deadly secretory diarrheal diseases at the molecular level, and for possible therapeutic intervention of the disease. The proposed study is highly innovative in both conceptual advance and in technology/technique development.
Public Health Relevance Statement
In this study we propose that the macromolecular complex of LPA2 and NHERF2 is regulated by LPA signaling, which further clusters the macromolecular complex to subdomain on the plasma membrane, and that the macromolecular complex plays important role in regulating compartmentalized cAMP level in proximity to CFTR channel, thus regulating CFTR-dependent electrolyte and fluid secretion in gut epithelial cells and in the mouse model. Therefore, the macromolecular complex plays an important role in pathogenic process of secretory diarrhea. By targeting the macromolecular complex, we may find ways to control fluid secretion and thereby control or cure the diarrheal disease.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
071284913
UEI
JZD1HLM2ZU83
Project Start Date
15-July-2011
Project End Date
30-June-2015
Budget Start Date
01-August-2013
Budget End Date
30-June-2014
Project Funding Information for 2013
Total Funding
$287,237
Direct Costs
$184,126
Indirect Costs
$103,111
Year
Funding IC
FY Total Cost by IC
2013
National Institute of Diabetes and Digestive and Kidney Diseases
$287,237
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01DK093045-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01DK093045-04
Patents
No Patents information available for 7R01DK093045-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01DK093045-04
Clinical Studies
No Clinical Studies information available for 7R01DK093045-04
News and More
Related News Releases
No news release information available for 7R01DK093045-04
History
No Historical information available for 7R01DK093045-04
Similar Projects
No Similar Projects information available for 7R01DK093045-04